Related Experiment Video
Updated: Nov 6, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
582
Obesity Management Education Needs Among General Internists: A Survey
Sanjeev Nanda1, Jayanth Adusumalli1, Ryan T Hurt1
1Mayo Clinic, Rochester, MN, USA.
Journal of Primary Care & Community Health
|May 5, 2021
Summary
Healthcare workers desire more training for managing overweight and obese patients. This need persists regardless of prior weight management education, highlighting a gap in current practices.
Area of Science:
- General Internal Medicine
- Healthcare Worker Education
Background:
- Obesity and overweight are significant public health concerns.
- Effective patient management requires healthcare provider expertise.
Purpose of the Study:
- To assess healthcare workers' knowledge, attitudes, experience, and training needs for managing overweight and obese patients.
- To identify specific areas where additional support and education are required.
Main Methods:
- A cross-sectional survey was emailed to 194 healthcare workers, including primary care providers (PCPs) and nurses.
- The survey focused on the management of patients with weight issues and collected data on demographics, prior training, and interest in further education.
Main Results:
- 80 participants completed the survey, with a majority being female and in their 30s or 50s.
- Nearly half reported some specialty training in weight management, with lectures being common.
- A significant majority (79%) expressed interest in further education on weight management or initiating conversations about weight.
Conclusions:
- Healthcare workers report a need for enhanced training in managing overweight and obese patients.
- This need for additional education is present even among those with previous training, indicating a persistent knowledge or skills gap.
Related Concept Videos
01:21Drug Dosing: Obese Patients
43
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
43
01:24Obesity
866
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
866
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
63
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
63
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
43
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
43
01:26Atherosclerosis III: Management
89
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
01:15Diabetes: Management and Pharmacotherapy
663
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
663